Superficial and Deep Endometriosis: Role of Systemic Inflammation as a Marker of Clinical, Surgical, and Reproductive Outcomes
NCT ID: NCT06470594
Last Updated: 2024-06-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
138 participants
OBSERVATIONAL
2024-05-29
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants already scheduled for surgery as part of their endometriosis care will be followed regarding the abovementioned outcomes after calculation of pre and postsurgical systemic inflammation markers (neutrophil to lymphocyte ratio; platelet to lymphocyte ratio and lymphocyte to monocyte ratio)
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quality of Life and Fertility of Patient With Deep Surgical Endometriosis: a Prospective Cohort
NCT03555903
EndometrioSis PRediction and Assessment of InflammaTion
NCT07114081
Prospective Study of the Outcomes of the Surgical Treatment of Deeply Infiltrating Endometriosis
NCT01105897
Symptoms and Quality of Life of Patients With Suspected Endometriosis
NCT05624567
Ultrasound Evaluation of the Pelvis in Women with Suspected Endometriosis Scheduled for Laparoscopic Surgery
NCT04171297
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Superficial Endometriosis
Laparoscopic excision of superficial (peritoneal) endometriotic implants
No interventions assigned to this group
Ovarian Endometriosis
Laparoscopic excision of ovarian endometrioma/s
No interventions assigned to this group
Deep Infiltrating Endometriosis (DIE)
Laparoscopic excision of DIE
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Postoperative follow-up of at least 12 months;
* Signature of informed consent regarding laparoscopic surgical treatment.
* Signature of informed consent to the processing of personal data duly documented by medical records.
Exclusion Criteria
* Histologic diagnosis of borderline tumor and/or ovarian carcinoma and/or mucinous cystadenoma and/or germ cell tumor or other malignancy of the genital tract
* postoperative follow-up of less than 12 months;
* documented history of inflammatory, rheumatologic, or immunologic disease; and
* failure to provide informed consent for personal data processing.
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Campania Luigi Vanvitelli
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gaetano Riemma
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Campania Luigi Vanvitelli
Napoli, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Gaetano Riemma
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0016489/i
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.